Target intelligence / Profile preview

Beta-defensin 105B (DEFB105B)

Target
DEFB105B
Molecular classification
Antimicrobial peptide, Host defense peptide, Beta-defensin family, Innate immune effector, Other
01

Overview

Beta-defensin 105B (DEFB105B) is a small, cationic antimicrobial peptide belonging to the beta-defensin family, which is widely implicated in the innate immune defense of epithelial surfaces against pathogens[1][6][7]. Like other beta-defensins, it is characterized by a structure containing six conserved cysteine residues forming three intramolecular disulfide bonds, giving the peptide a stable β-sheet conformation and amphipathic properties essential for disrupting microbial membranes[2][5]. Beta-defensin 105B exerts broad-spectrum antimicrobial activity, disrupting the membrane integrity of bacteria (both Gram-negative and Gram-positive), fungi, and some enveloped viruses[2][4][7]. The gene encoding Beta-defensin 105B is located on human chromosome 8p23, typically in a duplicated cluster alongside DEFB105A, with both genes producing nearly identical peptides expressed in epithelial tissues[1][6]. Beyond direct microbicidal effects, beta-defensins are recognized for immunomodulatory functions, including the recruitment and activation of immune cells such as dendritic cells, T lymphocytes, and mast cells via chemotactic activity[4][7]. While no drugs currently target this molecule directly, and it is not a classic pharmacological receptor or enzyme, its roles in immune defense and disease make it a protein of interest for infectious and inflammatory disease research[1][4][7]. **Note:** - There is no evidence in current major databases or literature that Beta-defensin 105B (DEFB105B) is misspelled, conceptually incorrect, or an invalid target.[1][6] - No specific drugs are known to target DEFB105B or use it as a biomarker; its therapeutic targeting is primarily theoretical at this time. - Its classification as a “target” is based on its established and broad roles as a direct effector in innate immunity, not as a receptor, enzyme, transporter, or classic drug target.

Other names
Beta-defensin 105DEFB105ABD5DEFB105DEFB5BD-5DEFB-5Beta-defensin 5Defensin, beta 105beta-defensin 105beta-defensin 5defensin, beta 105
02

Biological functions

Antimicrobial activity (against Gram-positive and Gram-negative bacteria, fungi, viruses)Innate immune responseModulation of immune cell chemotaxis (monocytes, T-cells, dendritic cells, mast cells)Disruption of microbial cell membranesImmune signaling (can enhance both innate and adaptive immune responses)
03

Disease associations

Infection (innate immunity, resistance to pathogens)Inflammation (immune modulation)Potential role in infertility (via sperm protection in related beta-defensins)Association with autoimmune/hyperinflammatory conditions (dysregulation)Other
04

Safety considerations

Overexpression or abnormal activation may contribute to inflammatory or autoimmune conditionsPotential cytotoxicity if dysregulated or used as therapeutic at non-physiological doses

Beyond the preview

Go deeper on Beta-defensin 105B (DEFB105B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-defensin 105B (DEFB105B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call